𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MODULATION OF HLA-DR ANTIGENS EXPRESSION IN HUMAN MYELOID LEUKAEMIA CELLS BY CYTARABINE AND 5-AZA-2'-DEOXYCYTIDINE

✍ Scribed by Pinto, Antonio; Maio, Michele; Attadia, Vincenza; Zappacosta, Serafino; Cimino, Renato


Book ID
121964191
Publisher
The Lancet
Year
1984
Tongue
English
Weight
434 KB
Volume
324
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rexpression of HLA class I antigens and
✍ Alfonso Serrano; Silvia Tanzarella; Ilaria Lionello; Rosa Mendez; Catia Traversa πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 230 KB πŸ‘ 1 views

Cell surface expression of HLA class I/peptide complexes on tumor cells is a key step in the generation of T-cell-based immune responses. Several genetic defects underlying the lack of HLA class I expression have been characterized. Here we describe another molecular mechanism that accounts for the

5-Aza-2β€²-deoxycytidine induces p21WAF ex
✍ Karin Schmelz; Mandy Wagner; Bernd DΓΆrken; Ingo Tamm πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 1005 KB

## Abstract The DNA methylation inhibitor 5‐Aza‐2′‐deoxycytidine (5‐Aza‐CdR) has significant therapeutic value for the treatment of patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). The demethylating effect of 5‐Aza‐CdR has been well char